Seattle Genetics Inc. (SGEN) on Thursday reported second-quarter net income of $76.3 million, after reporting a loss in the same period a year earlier.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,